News

What bioengineering can do for human health: the ESCEND example

ESCEND coordinator Vasilis Ntziachristos, together with Matthias Tschöp, CEO at Helmholtz Munich and Stephen Quake, Professor of Biomedical…
Read more

NIR-FME improves early lesion detection by 29% compared to the current clinical standard

In a recent ESCEND study we have shown that near-infrared fluorescence molecular endoscopy (NIR-FME) using the tracer cetuximab-800CW can strongly…
Read more

Project successfully completed: a game changer in esophageal cancer surgery

The ESCEND project has been completed with great success! Based on the exiting results from our phase-II clinical study using fluorescent agents…
Read more

There is a need for standardization in Near-infrared fluorescence molecular endoscopy (NIR-FME)

There is a need for standardization in Near-infrared fluorescence molecular endoscopy (NIR-FME) as indicated by researchers in the framework of…
Read more

Phase II early esophageal cancer detection study started

Results of real-time VEGFA-targeted NIR-FME
Our Phase II early esophageal cancer (EC) detection study ESCEND started, coordinated by Vasilis Ntziachristos. The study follows exciting results…
Read more

ESCEND is registered at clinicaltrials.gov

A Prospective Follow-up Intervention Study: Detection of Early Esophageal Cancer by Near-infrared Fluoresence Molecular Endoscopy Using…
Read more